Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03481309 · ClinicalTrials.gov registry record · NA
Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03481309 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 19 participants.
The verdict
NCT03481309, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
Investigating modulation of motor cortex excitability by transcranial magnetic stimulation and transcranial direct current stimulation.
Interventions
- DEVICE sham tDCS
- DEVICE anodal tDCS
- DEVICE cathodal tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-08-24 |
| Est. Completion | 2019-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03481309
The ClinicalTrials.gov registry entry for NCT03481309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which sham tDCS is the first listed.
NCT03481309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03481309 about?
NCT03481309 is a clinical study titled "Modulation of Motor Cortex Excitability by TMS and tDCS (MAGS1)". Investigating modulation of motor cortex excitability by transcranial magnetic stimulation and transcranial direct current stimulation.
What is the current status of trial NCT03481309?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2018-08-24. Estimated completion is 2019-02-01.
What interventions are being tested in trial NCT03481309?
The interventions under investigation include: sham tDCS (DEVICE), anodal tDCS (DEVICE), cathodal tDCS (DEVICE).
Who is sponsoring clinical trial NCT03481309?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.